SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001159036-21-000056
Filing Date
2021-12-10
Accepted
2021-12-10 16:08:26
Documents
13
Period of Report
2021-12-08
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K halo-20211208.htm   iXBRL 8-K 42735
2 EX-3.1 ex31-amendedandrestatedbyl.htm EX-3.1 139998
  Complete submission text file 0001159036-21-000056.txt   354274

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT halo-20211208.xsd EX-101.SCH 1915
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT halo-20211208_lab.xml EX-101.LAB 25138
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT halo-20211208_pre.xml EX-101.PRE 13055
6 EXTRACTED XBRL INSTANCE DOCUMENT halo-20211208_htm.xml XML 11321
Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32335 | Film No.: 211485361
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences